Overactive bladder, under scrutiny, gets a new treatment

被引：5
|
作者：
Opar, Alisa
机构：
来源：
NATURE MEDICINE | 2012年 / 18卷 / 08期
关键词：
D O I：
10.1038/nm0812-1159a
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1159 / 1159
页数：1
相关论文
共 50 条
  • [21] Medical treatment of overactive bladder
    Rackley, R
    Wein, A
    Nelson, D
    MAYO CLINIC PROCEEDINGS, 2001, 76 (11) : 1179 - 1179
  • [22] Tolterodine for the treatment of overactive bladder
    Salvatore, Stefano
    Serati, Maurizio
    Bolis, Pierfrancesco
    EXPERT OPINION ON PHARMACOTHERAPY, 2008, 9 (07) : 1249 - 1255
  • [23] Update on the treatment of overactive bladder
    Dmochowski, Roger R.
    Gomelsky, Alex
    CURRENT OPINION IN UROLOGY, 2011, 21 (04) : 286 - 290
  • [24] Solifenacin - Treatment of overactive bladder
    Chilman-Blair, K
    DRUGS OF TODAY, 2004, 40 (04) : 343 - 353
  • [25] TREATMENT OF OVERACTIVE BLADDER IN WOMEN
    Aydin, Y.
    Aslan, E.
    OXIDATION COMMUNICATIONS, 2016, 39 (04): : 3168 - 3179
  • [26] A treatment algorithm for the overactive bladder
    Van Kerrebroeck, PEV
    BJU INTERNATIONAL, 1999, 83 : 29 - 30
  • [27] Overactive bladder: diagnosis and treatment
    Vij, Monika
    Robinson, Dudley
    Cardozo, Linda
    WOMENS HEALTH, 2010, 6 (02) : 297 - 310
  • [28] The medical treatment of overactive bladder
    Beneton, C
    De Parisot, O
    NEUROCHIRURGIE, 2003, 49 (2-3) : 369 - 376
  • [29] Fesoterodine for the Treatment of Overactive Bladder
    Tzefos, Maria
    Dolder, Christian
    Olin, Jacqueline L.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (12) : 1992 - 2000
  • [30] MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER
    Gras, J.
    DRUGS OF TODAY, 2012, 48 (01) : 25 - 32
12345